The tumor necrosis factor-α converting enzyme (TACE):: A unique metalloproteinase with highly defined substrate selectivity

被引:176
|
作者
Mohan, MJ
Seaton, T
Mitchell, J
Howe, A
Blackburn, K
Burkhart, W
Moyer, M
Patel, I
Waitt, GM
Becherer, JD
Moss, ML
Milla, ME [1 ]
机构
[1] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Johnson Res Fdn, Philadelphia, PA 19104 USA
[3] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA
[4] Cognosci Inc, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/bi0260132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TNFalpha converting enzyme (TACE) processes precursor TNFalpha between Ala76 and Val77, yielding a correctly processed bioactive 17 kDa protein. Genetic evidence indicates that TACE may also be involved in the shedding, of other ectodomains. Here we show that native and recombinant forms of TACE efficiently processed a synthetic substrate corresponding to the TNFalpha cleavage site only. For all other substrates, conversion occurred only at high enzyme concentrations and prolonged reaction times. Often, cleavage under those conditions was accompanied by nonspecific reactions. We also compared TNFalpha cleavage by TACE to cleavage by those members of the matrix metalloproteinase (MMP) family previously implied in TNFalpha release. The specificity constants for TNFalpha cleavage by the MMPs were approximately 100-1000-fold slower relative to TACE. MMP 7 also processed precursor TNFalpha at the correct cleavage site but did so with a 30-fold lower specificity constant relative to TACE. In contrast, MMP I processed precursor TNFa between Ala74 and Gln75, in addition to between Ala76 and Val77, while MMP 9 cleaved this natural substrate solely between Ala74 and Gln75. Additionally, the MMP substrate Dnp-PChaGC(Me)HK(NMA)-NH2 was not cleaved at all by TACE, while collagenase (MMP 1), gelatinase (MMP 9), stromelysin I (MMP 3), and matrilysin (MMP 7) all processed this substrate efficiently. All of these results indicate that TACE is unique in terms of its specificity requirements for substrate cleavage.
引用
收藏
页码:9462 / 9469
页数:8
相关论文
共 50 条
  • [1] The tumor necrosis factor-α converting enzyme (TACE):: A unique metalloproteinase with highly defined substrate selectivity (vol 41, pg 9462, 2002)
    Mohan, MJ
    Seaton, T
    Mitchell, J
    Howe, A
    Blackburn, K
    Burkhart, W
    Moyer, M
    Patel, I
    Waitt, GM
    Becherer, JD
    Moss, ML
    Milla, ME
    BIOCHEMISTRY, 2003, 42 (37) : 11092 - 11092
  • [2] Heterocyclic inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Levin, Jeremy I.
    HETEROCYCLES, 2006, 70 : 691 - +
  • [3] Tumor necrosis factor-α-converting enzyme (TACE) levels in periodontal diseases
    Bostanci, N.
    Emingil, G.
    Afacan, B.
    Han, B.
    Ilgenli, T.
    Atilla, G.
    Hughes, F. J.
    Belibasakis, G. N.
    JOURNAL OF DENTAL RESEARCH, 2008, 87 (03) : 273 - 277
  • [4] Domain organization of the human tumor necrosis factor-α converting enzyme (TACE)
    Miller, AB
    Moss, M
    Mitchell, J
    Clay, W
    Carter, HL
    Buckhart, W
    Chen, WJ
    Didsbury, J
    Hoffman, C
    Jin, C
    Kost, T
    Lambert, M
    Leesnitzer, MA
    McCauley, P
    Moyer, M
    Pahel, G
    Su, JL
    Becherer, JD
    Milla, M
    FASEB JOURNAL, 1997, 11 (09): : A1225 - A1225
  • [5] Is tumor necrosis factor-α-converting enzyme (TACE) a therapeutic target for neuroprotection?
    Wang, XK
    DRUGS OF THE FUTURE, 2005, 30 (07) : 755 - 757
  • [6] Design of selective and soluble inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Rabinowitz, MH
    Andrews, RC
    Becherer, JD
    Bickett, DM
    Bubacz, DG
    Conway, JG
    Cowan, DJ
    Gaul, M
    Glennon, K
    Lambert, MH
    Leesnitzer, MA
    McDougald, DL
    Moss, ML
    Musso, DL
    Rizzolio, MC
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) : 4252 - 4267
  • [7] Tumor necrosis factor-α converting enzyme
    Black, RA
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01): : 1 - 5
  • [8] Genetic mapping of mouse tumor necrosis factor-α converting enzyme (Tace) to chromosome 12
    Yamazaki, K
    Mizui, Y
    Sagane, K
    Tanaka, I
    GENOMICS, 1998, 49 (02) : 336 - 337
  • [9] Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy
    Satoh, M
    Nakamura, M
    Saitoh, H
    Satoh, H
    Maesawa, C
    Segawa, N
    Tashiro, A
    Hiramori, K
    CIRCULATION, 1999, 99 (25) : 3260 - 3265
  • [10] Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability
    Sunnarborg, SW
    Hinkle, CL
    Stevenson, M
    Russell, WE
    Raska, CS
    Peschon, JJ
    Castner, BJ
    Gerhart, MJ
    Paxton, RJ
    Black, RA
    Lee, DC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) : 12838 - 12845